Thioredoxin Systems
About:
Thioredoxin Systems develops innovative antibiotic regimen for complicated urinary tract infections.
Website: https://www.txnsystems.com/
Top Investors: Annexstruktur, Mikael Lonn, Jens Mogensen, GOBIA Enterprises, GU Ventures
Description:
Thioredoxin Systems develops innovative antibiotic regimen for complicated urinary tract infections.
Total Funding Amount:
25M SEK
Headquarters Location:
Solna, Stockholms Lan, Sweden
Founded Date:
Founders:
Arne Holmgren
Number of Employees:
Last Funding Date:
2024-10-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai